Tebas, P., Kumar, P., Hicks, C., Granier, C., Wynne, B., Min, S., & Pappa, K. (2015). Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks. AIDS.

Tebas, Pablo, Princy Kumar, Charles Hicks, Catherine Granier, Brian Wynne, Sherene Min, und Keith Pappa. "Greater Change in Bone Turnover Markers for Efavirenz/emtricitabine/tenofovir Disoproxil Fumarate Versus Dolutegravir + Abacavir/lamivudine in Antiretroviral Therapy-naive Adults Over 144 Weeks." AIDS 2015.

Tebas, Pablo, et al. "Greater Change in Bone Turnover Markers for Efavirenz/emtricitabine/tenofovir Disoproxil Fumarate Versus Dolutegravir + Abacavir/lamivudine in Antiretroviral Therapy-naive Adults Over 144 Weeks." AIDS 2015.